4/11
11:21 am
lpcn
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics) [Yahoo! Finance]
Medium
Report
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics) [Yahoo! Finance]
4/11
07:22 am
lpcn
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity [Yahoo! Finance]
Medium
Report
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity [Yahoo! Finance]
4/11
07:00 am
lpcn
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Low
Report
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
4/11
02:04 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/3
02:04 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/28
08:09 am
lpcn
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis [Yahoo! Finance]
High
Report
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis [Yahoo! Finance]
3/28
08:00 am
lpcn
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Low
Report
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
3/26
02:32 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/8/2023
08:00 am
LPCN
lipocine inc.
MISS
Report
-1.2%
lipocine inc.
8/10/2023
08:00 am
LPCN
lipocine inc.
MISS
Report
-2.7%
lipocine inc.
4/11
07:25 am
lpcn
Form 8-K Lipocine Inc. For: Apr 11
High
Report
Form 8-K Lipocine Inc. For: Apr 11
3/28
06:26 am
lpcn
Form 8-K Lipocine Inc. For: Mar 28
Low
Report
Form 8-K Lipocine Inc. For: Mar 28
3/25
06:15 am
lpcn
Form 8-K Lipocine Inc. For: Mar 25
Medium
Report
Form 8-K Lipocine Inc. For: Mar 25
3/12
05:53 pm
lpcn
Form 4 Lipocine Inc. For: Mar 08 Filed by: Patel Mahesh V.
High
Report
Form 4 Lipocine Inc. For: Mar 08 Filed by: Patel Mahesh V.
3/12
05:51 pm
lpcn
Form 4 Lipocine Inc. For: Mar 08 Filed by: Fogarty Krista
High
Report
Form 4 Lipocine Inc. For: Mar 08 Filed by: Fogarty Krista
3/7
05:32 pm
lpcn
Form 8-K Lipocine Inc. For: Mar 07
Medium
Report
Form 8-K Lipocine Inc. For: Mar 07
3/7
06:10 am
lpcn
Form 8-K Lipocine Inc. For: Mar 07
Low
Report
Form 8-K Lipocine Inc. For: Mar 07
3/7
06:08 am
lpcn
Form 10-K Lipocine Inc. For: Dec 31
Low
Report
Form 10-K Lipocine Inc. For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register